US Patent Issued to Boehringer Ingelheim International on Sept. 30 for "Pharmaceutical composition, methods for treating and uses thereof" (Canadian, German, Norwegian, American, French, Swiss Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,162, issued on Sept. 30, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Pharmaceutical composition, methods for treating and uses thereof" was invented by Uli Christian Broedl (Mainz, Germany), Odd-Erik Johansen (Hoevik, Norway), Eric Williams Mayoux (Gambais, France), Nima Soleymanlou (Grand Island, N.Y.), Maximilian von Eynatten (Erding, Germany), Hans-Juergen Woerle (Cully, Switzerland), David Z. I. Cherney (Toronto) and Bruce A. Perkins (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or del...